Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-5 of 5 (Search time: 0.007 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
15-Sep-2021Preclinical Studies on the Effect of Rucaparib in Ovarian Cancer: Impact of Brca2 StatusSaravi, S; Alizzi, Z; Tosi, S; Hall, M; Karteris, E
20-Dec-2021Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review)Katopodis, P; Randeva, HS; Spandidos, DA; Saravi, S; Kyrou, I; Karteris, E
4-Aug-2023Identification of RAD51 foci in cancer-associated circulating cells of patients with high-grade serous ovarian cancer: Association with treatment outcomesAlizzi, Z; Saravi, S; Khalique, S; Mcdonald, T; Karteris, E; Hall, M
30-Jan-2024In Silico and In Vitro Mapping of Receptor-Type Protein Tyrosine Phosphatase Receptor Type D in Health and Disease: Implications for Asprosin Signalling in Endometrial Cancer and NeuroblastomaOrton, S; Karkia, R; Mustafov, D; Gharanei, S; Braoudaki, M; Filipe, A; Panfilov, S; Saravi, S; Khan, N; Kyrou, I; Karteris, E; Chatterjee, J; Randeva, HS
27-Apr-2024Effect of MYC and PARP Inhibitors in Ovarian Cancer Using an In Vitro ModelMorea, A; Saravi, S; Sisu, C; Hall, M; Tosi, S; Karteris, E; Storlazzi, CT